Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2225 of 3546 entries
View as:

Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database

Phase: N/A Priority: Normal
NCT ID: NCT01376258 Org: User:
Start: 10/31/10 End: 12/31/10 Due: 12/31/11

A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01340846 Org: User:
Start: 09/03/12 End: 11/14/12 Due: 11/14/13

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01444612 Org: User:
Start: 02/28/10 End: 11/30/10 Due: 11/30/11

Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00802737 Org: User:
Start: 01/31/09 End: 05/31/13 Due: 05/31/14

Vestipitant 28-day Tolerance Study

Phase: N/A Priority: Normal
NCT ID: NCT00992160 Org: User:
Start: 05/31/09 End: 09/30/09 Due: 09/30/10

Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT01153932 Org: User:
Start: 09/30/10 End: 09/30/12 Due: 09/30/13

Compassionate Use for Subcutaneous (SC) Belimumab

Phase: N/A Priority: Normal
NCT ID: NCT03125486 Org: User:
Start: - End: - Due: -

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

Phase: N/A Priority: Normal
NCT ID: NCT02000440 Org: User:
Start: 07/01/14 End: 05/11/16 Due: 05/11/17

Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02555371 Org: User:
Start: 01/07/16 End: 07/24/19 Due: 07/24/20

Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone

Phase: N/A Priority: Normal
NCT ID: NCT00551811 Org: User:
Start: 10/08/07 End: 07/22/08 Due: 07/22/09

Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01054885 Org: User:
Start: 10/19/09 End: 02/08/11 Due: 02/08/12

Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00742885 Org: User:
Start: 09/01/08 End: 03/07/09 Due: 03/07/10

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT01755689 Org: User:
Start: 01/11/13 End: 04/29/14 Due: 04/29/15

A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02374450 Org: User:
Start: 10/05/15 End: 08/02/22 Due: 08/02/23

A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody

Phase: N/A Priority: Normal
NCT ID: NCT03525678 Org: User:
Start: 06/18/18 End: 09/12/24 Due: 09/12/25

A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.

Phase: N/A Priority: Normal
NCT ID: NCT02839135 Org: User:
Start: 05/13/16 End: 08/10/16 Due: 08/10/17

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Phase: N/A Priority: Normal
NCT ID: NCT00043888 Org: User:
Start: 01/31/02 End: 05/31/03 Due: 05/31/04

Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01476111 Org: User:
Start: 12/31/11 End: 07/31/14 Due: 07/31/15

Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00297258 Org: User:
Start: 11/30/05 End: 02/28/14 Due: 02/28/15

Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00933062 Org: User:
Start: 03/23/09 End: 05/12/09 Due: 05/12/10

Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01128634 Org: User:
Start: 03/04/10 End: 04/26/10 Due: 04/26/11

An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010

Phase: N/A Priority: Normal
NCT ID: NCT01294553 Org: User:
Start: 06/30/04 End: 01/31/10 Due: 01/31/11

A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01929317 Org: User:
Start: 08/28/13 End: 06/09/15 Due: 06/09/16

Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT02141204 Org: User:
Start: 02/20/19 End: 12/28/19 Due: 12/28/20

Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan

Phase: N/A Priority: Normal
NCT ID: NCT03957577 Org: User:
Start: 06/13/19 End: 06/30/22 Due: 06/30/23